Cancer Screening
<p style="text-align: justify"> </p> <p style="text-align: justify"><span style="font-size: 12px"><span style="font-family: Helvetica, sans-serif; line-height: 150%">Cancer screening and early detection have major importance in the survival of patients with many cancers. A feature</span></span><span style="font-size: 12px"><span style="font-family: Helvetica, sans-serif; line-height: 150%"> common to most of the more prevalent cancers, i.e., cancers of the skin, breast, cervix, endometrium, ovary, testis, colon</span></span><span style="font-size: 12px"><span style="font-family: Helvetica, sans-serif; line-height: 150%"> and rectum, prostate, and lung, is that prognosis generally is better and treatment more successful if the disease is</span></span><span style="font-size: 12px"><span style="font-family: Helvetica, sans-serif; line-height: 150%"> detected when still localized.</span></span></p> <p style="text-align: justify"> </p> <p style="text-align: justify"><span lang="EN-US" style="font-size: 11.5pt; font-family: "Helvetica","sans-serif"; line-height: 150%"><o:p></o:p></span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%"><span style="font-size: 12px"><span lang="EN-US" style="font-family: Helvetica, sans-serif">T</span></span><span style="font-size: 12px"><span lang="EN-US" style="font-family: Helvetica, sans-serif">arcine has developed a variety of cancers early diagnostic reagents for clinical </span></span></p>